Opportunity Information: Apply for RFA AI 12 011
Apply for RFA AI 12 011
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Leadership Group for a Clinical Research Network on Integrated Strategies to Prevent HIV Infection (UM1)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242 Mental Health Research Grants 93.279 Drug Abuse and Addiction Research Programs 93.855 Allergy and Infectious Diseases Research 93.856 Microbiology and Infectious Diseases Research.
- This funding opportunity was created on Jan 27, 2012 and posted on Jan 27, 2012.
- Applicants must submit their applications by Sep 28, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Private institutions of higher education Small businesses County governments Others (see text field entitled Additional Information on Eligibility for clarification) State governments For profit organizations other than small businesses Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity (RFA-AI-12-011) is a National Institutes of Health cooperative agreement (UM1) focused on establishing the Leadership Group for a clinical research network dedicated to integrated strategies to prevent HIV infection. The central aim is to create a coordinated leadership structure that can design, run, and continuously refine a network-wide clinical research agenda aligned with NIAID HIV/AIDS scientific priorities. Because it is a cooperative agreement rather than a standard grant, awardees should expect substantial programmatic involvement from NIH/NIAID, with shared responsibility for shaping and executing the network's research activities.
The Leadership Group is expected to hold overarching responsibility for developing, implementing, and adapting the network's clinical research agenda. In practical terms, that means providing the organizational backbone that moves complex HIV prevention studies from concept to protocol to implementation, while ensuring that the network remains responsive to evolving scientific knowledge, public health needs, and NIAID priorities. The opportunity emphasizes integrated prevention strategies, which typically implies combining biomedical, behavioral, and other prevention approaches in a coordinated way, rather than evaluating single interventions in isolation, and doing so through a network capable of multi-site clinical research.
A defining requirement of this FOA is that applicants must submit three separate but linked UM1 applications that together form the Leadership Group. These components are a Leadership and Operations Center (LOC), a Laboratory Center (LC), and a Statistical and Data Management Center (SDMC). The LOC is generally the hub for scientific leadership, administrative management, study operations, communications, and coordination across sites and stakeholders. The LC is expected to provide centralized laboratory capacity and oversight, such as assay selection and validation, quality assurance, specimen handling standards, and harmonized laboratory procedures to ensure data comparability across studies and sites. The SDMC is intended to supply the statistical leadership and data infrastructure needed for network trials, including study design support, data capture and management systems, monitoring and reporting, analysis plans, and high-quality, auditable data workflows that meet clinical research standards.
The FOA is categorized as discretionary funding and uses the cooperative agreement instrument, with activity areas spanning education and health and referencing multiple CFDA program numbers (93.242, 93.279, 93.855, 93.856), reflecting the cross-cutting nature of HIV prevention research that can involve infectious diseases, microbiology, mental health, and substance use-related research domains. No cost sharing or matching is required, which reduces barriers for eligible organizations that might not have the ability to provide institutional matching funds.
Eligibility is broad across U.S.-based institutions and organizations, including public and private institutions of higher education, nonprofit organizations (including those with and without 501(c)(3) status, with specific conditions), small businesses, for-profit entities (other than small businesses), and a wide range of governmental entities (state, county, city/township, special district, and others). The FOA also explicitly includes various mission-driven and capacity-building institution types such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, faith-based or community-based organizations, and eligible federal agencies. Foreign institutions are not eligible to apply as primary applicants, but non-U.S. components of U.S. organizations are allowed, which supports international or cross-border research operations when managed through a U.S. applicant organization.
Key dates place this opportunity in the 2012 cycle: it was posted and created on January 27, 2012, with an original and current closing date of September 28, 2012, and an archive date of October 29, 2012. The sponsoring agency is NIH, with NIAID as the scientific home implied by the HIV/AIDS priorities and the RFA identifier. The full announcement was hosted on the NIH grants site, and the notice provides standard NIH Office of Extramural Research (OER) contact points for technical issues accessing the announcement online.
Funding Opportunity FAQs (RFA-AI-12-011)
1) What is this funding opportunity?
This opportunity (RFA-AI-12-011) is a National Institutes of Health (NIH) cooperative agreement (UM1) to establish the Leadership Group for a clinical research network focused on integrated strategies to prevent HIV infection.
2) What is the main goal of the award?
The central goal is to create a coordinated leadership structure that can design, run, and continuously refine a network-wide clinical research agenda that aligns with NIAID HIV/AIDS scientific priorities.
3) What does "integrated strategies to prevent HIV infection" mean in this context?
The opportunity emphasizes prevention approaches that are coordinated and combined (often biomedical and behavioral approaches, and potentially other prevention methods) rather than evaluating a single intervention in isolation, and doing so through a multi-site clinical research network.
4) What does it mean that this is a cooperative agreement (UM1) instead of a standard grant?
Because the award uses the cooperative agreement mechanism, awardees should expect substantial programmatic involvement from NIH/NIAID. Responsibility for shaping and executing the network's research activities is shared, rather than being entirely recipient-directed as in many standard grant mechanisms.
5) Who (or what) is the "Leadership Group" expected to be?
The Leadership Group is the coordinated set of required centers that together provide overarching responsibility for developing, implementing, and adapting the network's clinical research agenda, including moving studies from concept to protocol to implementation while staying responsive to evolving scientific knowledge, public health needs, and NIAID priorities.
6) How many applications are required, and how are they structured?
Applicants must submit three separate but linked UM1 applications that together form the Leadership Group. The three required components are:
- Leadership and Operations Center (LOC)
- Laboratory Center (LC)
- Statistical and Data Management Center (SDMC)
7) What is the role of the Leadership and Operations Center (LOC)?
The LOC generally serves as the hub for scientific leadership, administrative management, study operations, communications, and coordination across sites and stakeholders.
8) What is the role of the Laboratory Center (LC)?
The LC is expected to provide centralized laboratory capacity and oversight. Examples of responsibilities described include assay selection and validation, quality assurance, specimen handling standards, and harmonized laboratory procedures so that data are comparable across studies and sites.
9) What is the role of the Statistical and Data Management Center (SDMC)?
The SDMC is intended to provide statistical leadership and the data infrastructure needed for network trials. This includes supporting study design, providing data capture and management systems, monitoring and reporting, developing analysis plans, and maintaining high-quality, auditable data workflows consistent with clinical research standards.
10) What kinds of activities is the Leadership Group responsible for?
The Leadership Group is expected to develop, implement, and adapt the network's clinical research agenda and provide the organizational backbone needed to run complex HIV prevention studies across sites, from early concepts through protocol development and study implementation.
11) Which NIH Institute or scientific area is associated with this RFA?
The opportunity is an NIH announcement and is described as aligned with NIAID HIV/AIDS scientific priorities, consistent with the RFA identifier (RFA-AI-12-011) and the stated HIV prevention research focus.
12) Is this opportunity mandatory cost-sharing or matching?
No. The announcement specifies that no cost sharing or matching is required.
13) What type of funding category is this?
The FOA is categorized as discretionary funding.
14) Which CFDA program numbers are referenced?
The opportunity references multiple CFDA program numbers: 93.242, 93.279, 93.855, 93.856. These reflect the cross-cutting nature of HIV prevention research that may involve infectious diseases, microbiology, mental health, and substance use-related research domains.
15) Who is eligible to apply?
Eligibility is broad across U.S.-based institutions and organizations. The announcement includes, among others:
- Public and private institutions of higher education
- Nonprofit organizations (including those with and without 501(c)(3) status, with specific conditions)
- Small businesses
- For-profit entities (other than small businesses)
- Governmental entities (state, county, city/township, special district, and others)
- Eligible federal agencies
- Mission-driven and capacity-building institution types such as HBCUs, Hispanic-serving Institutions, TCCUs, Alaska Native and Native Hawaiian Serving Institutions
- Faith-based or community-based organizations
16) Are foreign institutions eligible to apply as the primary applicant?
No. Foreign institutions are not eligible to apply as primary applicants for this opportunity.
17) Can a U.S. organization include non-U.S. components in the project?
Yes. While foreign institutions cannot be primary applicants, non-U.S. components of U.S. organizations are allowed. This supports international or cross-border research operations when managed through a U.S. applicant organization.
18) When was this opportunity posted, and what are the key dates?
The announcement was posted and created on January 27, 2012. The original and current closing date is September 28, 2012. The archive date is October 29, 2012.
19) Is the opportunity still open?
Based on the dates provided (closing date September 28, 2012 and archive date October 29, 2012), this funding opportunity is part of the 2012 cycle and is archived.
20) Where was the full announcement hosted, and who is listed for technical access issues?
The full announcement was hosted on the NIH grants site. The notice references standard NIH Office of Extramural Research (OER) contact points for technical issues accessing the announcement online.
Browse more opportunities from the same category: Education Health
Next opportunity: Leadership Group for a Clinical Research Network on Vaccines to Prevent HIV infection (UM1)
Previous opportunity: Leadership Group for a Clinical Research Network on Microbicides to Prevent HIV Infection (UM1)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AI 12 011
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AI 12 011) also looked into and applied for these:
| Funding Opportunity |
|---|
| Cutting Edge Basic Research Awards (CEBRA) (R21) Apply for PAR 12 086 Funding Number: PAR 12 086 Agency: National Institutes of Health Category: Education Health Funding Amount: $125,000 |
| Basic Cancer Research in Cancer Health Disparities (U01) Apply for PAR 12 095 Funding Number: PAR 12 095 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Exploratory/Developmental Grants Program for Basic Cancer Research in Cancer Health Disparities (R21) Apply for PAR 12 094 Funding Number: PAR 12 094 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21) Apply for PAR 12 096 Funding Number: PAR 12 096 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Phased Services Research Studies of Drug Use Prevention, Addiction Treatment, and HIV in an Era of Health Care Reform (R21/R33) Apply for RFA DA 13 001 Funding Number: RFA DA 13 001 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Centers of Excellence in Symptom Science (P30) Apply for RFA NR 12 006 Funding Number: RFA NR 12 006 Agency: National Institutes of Health Category: Education Health Funding Amount: $480,000 |
| Centers of Excellence in Symptom Science Building Research Teams for the Future (P20) Apply for RFA NR 12 009 Funding Number: RFA NR 12 009 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| NLM Information Resource Grants to Reduce Health Disparities (G08) Apply for RFA LM 12 001 Funding Number: RFA LM 12 001 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| The NCI Transition Career Development Award (K22) Apply for PAR 12 121 Funding Number: PAR 12 121 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco Abuse (R01) Apply for PA 12 127 Funding Number: PA 12 127 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco Abuse (R21) Apply for PA 12 128 Funding Number: PA 12 128 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco Abuse (R03) Apply for PA 12 129 Funding Number: PA 12 129 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Abuse (R34) Apply for PA 12 130 Funding Number: PA 12 130 Agency: National Institutes of Health Category: Education Health Funding Amount: $225,000 |
| Research to Assist Informal Caregivers in Assessing and Managing Symptoms in Individuals with Alzheimers Disease (R01) Apply for RFA NR 12 011 Funding Number: RFA NR 12 011 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
| Translational Research at the Aging/Cancer Interface (TRACI) (R21) Apply for PA 12 135 Funding Number: PA 12 135 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Translational Research at the Aging/Cancer Interface (TRACI) (R01) Apply for PA 12 136 Funding Number: PA 12 136 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Early Detection and Prevention of Mild Cognitive Impairment (R01) Apply for RFA NR 12 010 Funding Number: RFA NR 12 010 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
| Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01) Apply for PAS 12 122 Funding Number: PAS 12 122 Agency: National Institutes of Health Category: Education Health Funding Amount: $2,000,000 |
| Technology Based Interventions to Promote Engagement in Care and Treatment Adherence for Substance Abusing Populations with HIV (R01) Apply for PA 12 117 Funding Number: PA 12 117 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Technology Based Interventions to Promote Engagement in Care and Treatment Adherence and For Substance Abusing Populations with HIV (R34) Apply for PA 12 118 Funding Number: PA 12 118 Agency: National Institutes of Health Category: Education Health Funding Amount: $225,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AI 12 011", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.